Home » Technology

Enterprise Tech Ecosystem Series – Novartis AG

Novartis AG (Novartis) is a pharmaceutical company engaged in discovery, development, manufacturing, and marketing of prescription and generic pharmaceutical products. It provides drugs for the treatment of cancer, cardiovascular diseases, dermatological conditions, neurological disorders, ophthalmic diseases, respiratory diseases, immune disorders and infections, among others. The company offers eye care products through its subsidiary, Alcon, and generic medicines through Sandoz.


The report provides information and insights into Novartis AG , including –

– Insights of its digital transformation strategies

– Details of various innovation programs, partnerships, in-house launches, and other industry engagement programs

– Details of investments into various disruptive technologies

– Detailed overview of Novartis AG's financial highlights.

Reasons to Buy

– Gain insights into Novartis AG technology innovations.

– Gain insights into its strategy and investment portfolio.

– Gain insights into various product launches, partnership strategies and investments of Novartis AG.

– Gain insights into various disruptive technologies, digital transformation initiatives, partnerships and tech initiatives of the Company.

Key Players

Pear Therapeutics



Tech Mahindra

Feet Me

Propeller Health

Table of Contents

Table of Contents


Digital Transformation Strategy

Innovation Lab/Development Programs

Technology Focus

Technology Initiatives

Key Executives

Venture Arm – Novartis Venture Fund (NVF)

Novartis Venture Fund Investments

ICT Budget & Contracts

Investor – Partner Network Map


Discounts available for multiple purchases.

+44 20 7947 2960

Join our mailing list

Saved reports